What to expect with COVID-19 vaccines for kids ages 5 to 11
Here’s what the science reveals about the safety of the Pfizer shot for this age group, the doses involved, and the role it will play in protecting everyone from the disease.
American families who are eagerly awaiting the ability to vaccinate their young children against COVID-19 may finally get their wish in the coming weeks.
On Friday, October 29, the U.S. Food and Drug Administration authorized Pfizer-BioNTech shots for kids ages 5 to 11. The move comes just days after an advisory committee reviewed the safety and effectiveness of the low-dose vaccine and voted unanimously in favor of it. If the Centers for Disease Control and Prevention follows suit in the coming days, the 28 million children in this age group will be able to join their older siblings and parents in getting the jab.
Documents sent to the FDA and released by Pfizer on October 22 provide results from their clinical trial
